. Author manuscript; available in PMC: 2022 Dec 15.

Published in final edited form as: Radiology. 2020 Mar 17;295(2):418–427. doi: 10.1148/radiol.2020192256

Table 3:

Estimated Effective and Collective Dose with ICRP Publication 60 versus ICRP Publication 103 Using the ICRP Phantom for Various Nuclear Medicine Procedures

Study Type	No. of Procedures^*	E₆₀ Per Procedure (mSv)	ICRP 60 Collective Dose (Person-Sv)^*	E₁₀₃ Per Procedure (mSv)	ICRP 103 and ICRU Collective Dose (Person-Sv)^†	Ratio of ICRP 103 and ICRP 60 Values
Cardiac (including PET)	6 440 000 (47.6)	12.9	82 918 (62.2)	9.7	62 159 (58.7)	0.75
Tumor (PET)	1 970 000 (14.6)	14.1	27 698 (20.8)	12.7	24 928 (23.5)	0.90
Bone and marrow	1 670 000 (12.3)	5.3	8934 (6.7)	4.0	6659 (6.3)	0.745
Gastrointestinal	930 000 (6.9)	3.2	2941 (2.2)	2.9	2684 (2.5)	0.913
Thyroid	590 000 (4.4)	4.7	2784 (2.1)	4.5	2648 (2.5)	0.951
Tumor (non-PET)	400 000 (3.0)	6.4	2564 (1.9)	4.1	1622 (1.5)	0.633
Inflammation	280 000 (2.1)	6.1	1719 (1.3)	5.9	1641 (1.5)	0.955
Neurology (including PET of brain)	200 000 (1.5)	7.7	1532 (1.2)	6.6	1316 (1.2)	0.859
Lung	690 000 (5.1)	1.8	1231 (0.9)	2.5	1740 (1.6)	1.414
Genitourinary	360 000 (2.7)	2.5	901 (0.7)	1.4	517 (0.5)	0.574
Total	13 530 000 (100)	…	133 222 (100)	…	105 914 (100)	0.795

Note.—Data are for procedures in the United States in 2016. The effective dose per category depends on assumptions made in distribution of specific procedures, distribution of radiopharmaceuticals used, administered activity, and dose conversion coefficients for radiopharmaceuticals in that category. E₆₀ = effective dose based on International Commission on Radiological Protection (ICRP) Publication 60 (8), E₁₀₃ = effective dose based on ICRP Publication 103 (9), ICRU = International Commission on Radiological Units and Measurements. Adapted with permission of the National Council on Radiation Protection and Measurements.

Numbers in parentheses are the percentage of the total.

^†

Numbers in parentheses are percentages.